Session Information
2012 Midyear Clinical Meeting
Click here to go to the previous page
Management Case Studies L: Part 1
Track: Education Sessions (CE)
Program Code: 374-L05
Date: Wednesday, December 5, 2012
Time: 8:00 AM to 8:30 AM EST
Location: South Seas B, Level 3, South Convention Center
PRESENTER(S):
Dr. Leigh DeMarco, PharmD, MS, Pharmacy Manager, Huntsman Cancer Hospital
 Carolyn Kowalchik, RPh, MSs, Director of Pharmacy, University of Utah Hospitals & Clinics
Dr. Brad Myers, PharmD, MBA, BCPS, System Director, Sentara Healthcare
 Linda Tyler, PharmD, Administrative Director, Pharmacy Services, University of Utah Hospitals & Clinics
PROGRAM CHAIR:
Brian Esuchanko
Description
Using Failure Mode Effects Analysis (FMEA) to Improve Controlled Substances Processes in Inpatient Areas

  • Describe the steps of a FMEA.
  • Identify three factors to make a FMEA project more successful.
  • List three system vulnerabilities for handling controlled substances that can be identified through a FMEA process.


Audio Synchronized to PowerPoint
(Code: 374-L05)
Attendee:Free
  
This session is a part of: